Skip to main content
logo
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.750
+0.110 (3.02%)
Mar 31, 2026, 4:00 PM EDT - Market closed

ADC Therapeutics Revenue

In the year 2025, ADC Therapeutics had annual revenue of $81.36M with 14.85% growth. ADC Therapeutics had revenue of $23.06M in the quarter ending December 31, 2025, with 36.36% growth.

Revenue (ttm)
$81.36M
Revenue Growth
+14.85%
P/S Ratio
5.86
Revenue / Employee
$421,539
Employees
193
Market Cap
476.42M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202581.36M10.52M14.85%
Dec 31, 202470.84M1.28M1.84%
Dec 31, 202369.56M-140.35M-66.86%
Dec 31, 2022209.91M175.99M518.89%
Dec 31, 202133.92M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rigel Pharmaceuticals294.28M
4D Molecular Therapeutics85.21M
Fulcrum Therapeutics80.00M
Aclaris Therapeutics7.83M
Upstream Bio2.85M
ProKidney893.00K
Lyell Immunopharma36.00K
vTv Therapeutics17.00K
Revenue Rankings

ADCT News

More News